Conference Exhibitors

Action for Pulmonary Fibrosis is a patient-driven charity.

Our four themes
1. Support
To advocate for patients and to provide support to improve their quality of life and to develop collaborative partnerships to help fund patient-focused support programmes

2. Research
To support research into improved outcomes and greater understanding of the disease and to champion research programmes

3. Education
To undertake targeted awareness raising of the disease, amongst the medical profession, decision-makers and the wider public

4. Campaigning
To proactively target parliamentarians, NHS and policy-makers and to represent patient interests with NICE and the NHS and to target symptom recognition in primary care for prompt diagnosis.

Adherium’s Hailie® Digital Inhaler technology and cloud-based data platform provides real-time feedback on patients' use of inhaled medication, enabling optimal management of difficult-to-treat and severe asthma and COPD, and reduce direct and indirect healthcare costs.

Adherium Limited is an international Respiratory eHealth company focused on patient medication adherence, remote monitoring, and data management solutions for patients, payers, and providers.

We are a dynamic pharmaceutical company who are committed to building and nurturing meaningful partnerships with our customers in the UK. We are dedicated to delivering a growing portfolio of high quality products to help improve patient outcomes, at responsible prices. This is in accordance with our values of Integrity, Partnership and Reliability.

Established in 2009, Aspire Pharma has become one of the fastest growing pharmaceutical companies in the UK.  Supplying a range of pharmaceuticals, medical devices and diagnostics, Aspire’s products are carefully selected to deliver value and differentiation to both patients and prescribers. Thanks to the company’s continued expansion, it is now a significant employer in the East Hampshire area, and continues to focus on extending its portfolio of innovative products, as well as furthering its position in the areas of ophthalmology and urology. For more information on the company and their products, visit www.aspirepharma.co.uk.

The Association of Chartered Physiotherapists in Respiratory Care promotes health and best practice in respiratory physiotherapy for the benefit of all. With over 1800 members the ACPRC is the largest national body of Physiotherapists interested in all aspects of Respiratory Care. Connecting with our members is at the heart of our organisation, and in addition to our ACPRC Conference which is taking place in April 2023 we also engage with members via:
• Regular short courses
• Monthly e-Newsletters with latest updates for our members
• A dedicated ACPRC Facebook page www.facebook.com/TheACPRC
• Monthly twitter chats via our ACPRC twitter account - twitter.com/TheACPRC
• A website which is packed with resources for members www.acprc.org.uk
• Support with publishing your research
• Education grants
Furthermore, we support the development of National Guidelines related to cardio-respiratory care
and aim to publish 2 journals a year which is delivered electronically to every one of our 1800+
members.

Contact information:
Email: secretary@acprc.org.uk

The Association of Respiratory Nurse Specialists (ARNS) was established in 1997 as a nursing forum to champion the specialty respiratory nursing community, promote excellence in practice, and influence respiratory health policy. ARNS also works to influence the direction of respiratory nursing care.

Asthma Patients Can Now Breathe Easy.
CAIRE® Diagnostics enables asthma patients to live with confidence through better monitoring and control. CAIRE® Diagnostics manufactures Fenom Pro®, a simple, easy to use, point of care device that measures Fractional exhaled Nitric Oxide (FeNO). FeNO is an accepted biomarker for inflammation associated with allergic asthma. CAIRE® Diagnostics is working to create broader access to FeNO testing for all asthmatics regardless of where they seek care around the world. Find out more about CAIRE® Diagnostics and Fenom Pro® at www.fenomasthma.com.

Chiesi Limited headquartered in Manchester, employs over 400 people. Based in Parma, Italy, Chiesi Farmaceutici is an international research-focused group with over 85 years’ experience in the pharmaceutical sector operating in 30 countries, employing around 6,000 people. Chiesi’s Parma based Research and Development Centre coordinates the activities of six other centres in France, U.S.A, Canada, China, UK, and Sweden to promote its pre-clinical, clinical, and regulatory programmes. To achieve its mission of improving people’s quality of life by acting responsibly towards society and the environment, Chiesi researches, develops and markets drugs in its three therapeutic areas: AIR (respiration, new-born to adult populations), RARE (rare and ultra-rare diseases) and CARE (special care and consumer-facing self-care). Chiesi, since 2019, is the world’s largest B Corp certified pharmaceutical group. The global B Corp movement promotes business as a force for good. The Group is committed to becoming carbon neutral by the end of 2035. Further information: www.chiesi.uk.com

In the 1970’s, Clement Clarke International (CCI) developed the Mini-Wright Standard Peak Flow Meter. Over 40 years later, it remains the ‘Gold Standard’ due to quality, specificity and price. In addition, CCI have a range of Spacer devices; including a DispozABLE Spacer, a paper like-cup for emergency SABA delivery. The improved Able Spacer, which features a 2 way valve, operating at less than 10L/min inspiratory flow, is simple and easy to use, highly recommended for children and COPD patients or those with inconsistent or breathing difficulties. For all other Respiratory patients, it simply offers a suitable and robust system for better drug delivery and peace of mind. Made from an anti-microbial and low static plastic, CCI’s portfolio comprises of an extensive range of inhaler technique training tools which have been developed to work with or without a supportive app. Thereby, offering a fun and engaging solution to training and better drug delivery for patients that need their drugs, in the lungs.

Circassia is a dedicated diagnostics and management company focused on asthma. Our market-leading NIOX® products are used by physicians around the world to help improve asthma diagnosis and management, and we support our customers with dedication to outstanding customer service and after sales support.
Our purpose is to improve the quality of life for millions of people suffering from asthma.
As the leading provider of point-of-care FeNO diagnosis and management products we are making good progress, helping healthcare professionals manage their patients’ asthma.

We believe every asthma patient should have access to the best care. To help achieve this, we are working hard to provide our customers with outstanding support, while devoting ourselves to developing the next generation of NIOX® innovations.

GSK has been a leader in respiratory for more than 50 years, helping patients with respiratory disease better manage their condition. Working in collaboration with the scientific community, GSK remains at the cutting edge of scientific research into innovative medicines with the aim of helping patients’ symptoms and reduce the risk of their disease. For further information for UK HCPs, please visit https://gskpro.com/en-gb/

NP-GB-RS-WCNT-220003, September 2022

Our mission at Glenmark Respiratory UK is to be a consistent presence in the UK respiratory market with an unwavering focus on patients. We believe in working with healthcare providers to help overcome barriers they face. We value simplicity and efficiency, values that are upheld by our respiratory brands.

For 25 years, Intermedical (UK) Ltd has lead the way in providing innovative respiratory diagnostic technologies for our healthcare services. Our primary care division comprises of a specialist range of diagnostic equipment designed for use for an array of clinical applications including Spirometry, Asthma diagnosis and management, Respiratory monitoring and more. Showcased at the PCRS conference is the Bedfont® NObreath® FeNO monitor. It is a simple to use, battery-powered handheld monitor that measures Fractional exhaled Nitric Oxide (FeNO) in the breath. With very little respiratory effort, this simple test analyses the breath sample to give instant, accurate results every time.
FeNO testing and the general upkeep of equipment has notoriously been expensive – until now! Come and visit us at Stand 15 to discover more.

At Johnson & Johnson Consumer Health, we are driven to improve the personal health of consumers around the world. Every day, more than 1.2 billion people reach for our trusted products to take care of themselves and those they love. Our business is built on a strong and proud heritage, driven by the values of Our Credo. Our self-care, essential health and skin health brands are rooted in science and endorsed by professionals. We are 19,000 employees strong, meeting the needs of consumers around the world and making a sustainable, positive, and enduring impact on their personal health.

Lupin Healthcare are proud to provide high quality medicines to patients that deliver both quality and value to the NHS.

National Services for Health Improvement (NSHI) Ltd. www.nshi.co.uk are an independent service provider committed to delivering both in-practice and remote health care services that make a real difference to patients. As a leading supplier of specialist nursing services to both the NHS and Pharmaceutical sector our teams have helped to support patients in over 6,500 practices and 25 Hospital Trusts. We have provided review services for patients with asthma, COPD, cardiovascular disease, migraine other long-term conditions. In addition, we also provide locality wide services for spirometry assessment and the national immunisation programme.

NSHI look to embrace healthcare technology and have global leading medical software solutions that we have developed alongside our sister organisation LungHealth www.lunghealth.co.uk
We provide patient identification, risk stratification and patient review solutions (guided consultation software). Our COPD and Sleep software solutions are now NHS Framework (LPP) listed and have ORCHA digital accreditation. The products are designed to support practices who may not have the benefit of specialist respiratory nurse resource or to augment existing specialist resource in Hospital Trusts.

SPIROCONNECT SPIROMETER
SpiroConnect is the most accurate, comprehensive, and simple to use spirometry solution available. Bluetooth connectivity allows the respiratory nurse to be isolated from the patient during a test if necessary, giving extra protection should a coughing event occur. SpiroConnect is fully integrated with EMIS, SystmOne and Vision making it safer, faster and easier to use. It is also fully compliant with the latest ATS/ERS 2019 spirometry update. In addition to all of the features that you would expect in a leading spirometry system, ArtiQ.Spiro quality and interpretation reports are also available for those users with an active ArtiQ.Spiro account.

SpiroConnect can be purchased outright or rented from just £41 + VAT per month, including installation, product training, clinical system integration and Numed's comprehensive MediServe support package.

WHAT DO OUR CUSTOMERS THINK?
“As a Respiratory Nurse Specialist with over 14 years’ experience delivering spirometry training in the Primary Care sector, I have used all makes and models of spirometer. I was introduced to the SpiroConnect system around 6 years ago. The design, accuracy and ease of use of SpiroConnect, in addition to after sales support and commitment to product development is the best I’ve ever experienced. I now recommend SpiroConnect to any practice/hub looking to upgrade their spirometry equipment” - SOPHIE TOOR – Primary Care Respiratory Nurse Specialist and Clinical Director of Respiratory Matters, a leading spirometry training provider.

FeNO AND CO BREATH TESTING
New to our respiratory range are the Bedfont NObreath FeNO monitor and a range of Carbon Monoxide breath testing equipment from MD Diagnostics.

For more information, visit the Numed Healthcare stand at the PCRS exhibition or contact us:

Website: www.numed.co.uk
Email: info@numed.co.uk
Telephone: 0114 2433896

Orion Pharma (UK) Ltd is a subsidiary of Orion Corporation, pharmaceutical company based in Finland. Orion carries out extensive research with a goal of introducing new treatments into global markets. The core therapy areas of Orion are neurological disorders, oncology and respiratory disease.

www.orionpharma.co.uk

August 2022/CORP-233(1)

The aim of the Pulmonary Fibrosis Trust is to provide personal support to people affected by Pulmonary Fibrosis, a very debilitating and life-limiting illness.

We offer practical, emotional and financial support where there is a need. We also raise awareness of the illness and in particular the challenges people face on a daily basis.

Pulmonx is a global leader in interventional pulmonology, planning tools, and treatments for obstructive lung disease and is the maker of the Zephyr Endobronchial Valve. Zephyr Endobronchial Valves are a NICE approved and NHS England commissioned, minimally invasive treatment for lung volume reduction in breathless patients with Severe Emphysema.

Sandoz, a division of the Novartis group, is a global leader in generic medicines, and is committed to playing a leading role in driving access to medicines worldwide. Sandoz contributes to society’s ability to support growing healthcare needs by pioneering a variety of approaches to help people around the world access high-quality medicine.
https://www.sandoz.uk.com/

IMPROVE Trial: Improving completion of Pulmonary Rehabilitation with PR-buddies
We are looking for PR services to take part in a national trial of recruiting and training PR-buddies to improve the uptake and completion of PR funded by the National Institute of Health and Care Research (NIHR). This is a national cluster randomised trial. The PR-buddies will be volunteers, who have successfully completed PR, trained in communication skills and the use of behaviour change techniques to help patients overcome the obstacles that could stop them from doing PR.
We are seeking expressions of interest from PR services interested in becoming a trial site. Initially we are focusing recruitment of sites to London; Kent, Surrey and Sussex; the West Midlands; Yorkshire and Humberside; and Greater Manchester. There will be a pilot beginning in summer 2022, with the main trial starting early in 2023.
For more information please contact the IMPROVE trial manager: Toby Morgan E-mail: toby.morgan@kcl.ac.uk. Tel: 0207 848 8679
Also see the IMPROVE trial website – www.improvetrial.co.uk

At Simpson Millar Solicitors, our process is designed to make your experience with us as easy and effective as possible. Through transparent communication and high-quality legal services, you can rest assured knowing your case is in the best hands.

Our Industrial Disease Solicitors can help you claim compensation for a work related illness and access the care and support you need. You deserve to be protected at work to ensure your safety is maintained. We have a huge amount of experience fighting for justice on behalf of our clients and offer a Free assessment to see if you have a claim for compensation. We also work on a No Win, No Fee basis so there is no financial risk to you.

Smart Asthma Monitoring is a Virtual Ward to reduce the overall burden of asthma, using digital health. Smart Respiratory are excited to launch our innovative Smart Rescue inhaler counter, which measures and time stamps the number of SABA puffs, as well as providing a dose counter to prevent patients discarding half full inhalers. Reducing pMDI use for environmental use is one of the goals of Net Zero NHS and Salbutamol accounts for approximately 50% of all prescribed pMDIs. To make a meaningful impact on Salbutamol use (either health benefits or Net Zero NHS), our strategy is to identify the large number of asthmatics on 6 or more annual SABA prescriptions and risk identification tools can help. We would invite these patients to join a programme to reduce SABA over-reliance using our Smart Rescue sensor and would like to work with interested PCNs and Trusts to implement this. If you are interested in learning more about Smart Rescue or Smart Asthma Monitoring, please visit our stand for a demo.

STADA UK (Thornton and Ross) are one of the UK's fastest-growing, leading producers of household pharmaceutical products. With almost 100 years’ heritage behind us, we are also a trusted and reliable provider of prescription products to the NHS with a portfolio spanning respiratory, dermatology, bone health and generics.

As a global leader in Allergy and Autoimmune diagnostics, we are committed to providing clinically relevant testing solutions to aid in the proper disease diagnosis and patient management. Asthma patients who are aware of their allergic triggers manage their condition better. We offer over 650 allergen tests and a range of autoimmune test, referenced in over 6,000 publications and guidelines. ImmunoCap is considered the Gold Standard in Specific IgE blood testing.

riOn Pharma is a rapidly growing UK pharmaceutical company having two operations; licence pharma products and wholesaling. TriOn product portfolio contains Pharmaceutical, Nutraceuticals and Medical Devices offering significant cost saving for NHS. TriOn Respiratory specialist’s products consist of PulmoClear- Hypertonic NaCl for inhalation solution 3%,6% & 7% and Inhaler spacer device as EasyChamber Spacer in all 4 variance, are now available on prescription in the UK with great saving for NHS/clinicians. Please visit our stand for more information and product sample; info@trionpharma.co.uk

Breathe Better. Live Fuller.
Trudell Medical International works with patients, their caregivers and healthcare professionals to help patients all over the world breathe better and live fuller lives. We manufacture and globally market some of the leading brands in respiratory care including the AeroChamber* brand of spacers, the Aerobika* OPEP devices, the TruZone* Peak Flow Meter, and the AEROECLIPSE* BAN* nebulizers.

Trudell Medical International is headquartered in London, Canada with regional sales/representative offices in the UK, Spain, Portugal, Egypt and Japan. Our products are distributed to patients and customers in over 100 countries. Our clinically proven, award winning products are backed by science and supported with 100+ peer reviewed articles in leading clinical journals.

Please visit www.trudellmed.com for further details on our company and our products.

Our mission is to improve patients lives by providing market leading products and services. Our intention is to have an impact in the effective management of respiratory diseases. We provide a wide variety of precise, intuitive devices for respiratory care including spirometers, lung & asthma monitors, COPD screeners, ECG, FeNO, and medical workstations as well as software and consumables.
We are excited to showcase our next generation PC-based, desktop and handheld spirometers. Compliant with the 2019 ATS/ERS spirometry update, these devices ensure your service meets the latest international guidelines on accuracy and reporting. Their brand-new intuitive interfaces automatically grade tests and provide quality control feedback for easy and rapid testing.
For further peace of mind these come with FREE 5 YEAR WARRANTY and FREE ONLINE DEVICE TRAINING and FREE CONNECT electronic medical record interface software.
Protect your patients, staff, and equipment with an Eco BVF™, suitable for most leading brands of spirometers. Independently validated 99.999% bacterial and viral cross-contamination efficiency, these filters are made using less plastic, are lighter to transport, and are made from 100% recyclable materials.
Our friendly and knowledgeable experts will be available throughout the conference to chat about your needs.
Visit www.vitalograph.co.uk or call 01280 827110.

At Zentiva, it is our aspiration that healthcare should be a right and not a privilege. More than ever, people need better access to high-quality affordable medicines and healthcare. Visit us at www.zentiva.co.uk